US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 7, 2022 (4 years ago)

Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.

What was recalled

Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC 60505-2676-3, UPC 3 60505 26763 7), Rx only, Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326

Recalling firm
Apotex Corp.
NDC code
60505-2676-8
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1285-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Aripiprazole recalls

See all